. . .the publication�s purpose is to be a "force for good and a platform for much needed change and to generate critical debate". http://lm360.us/Jing-grandma-of-Reffett-from-Scorton?Macahilas=135 . cambridge's bluebird bio licenses delivery tech to novartis, gsk . . .